Document Detail


Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil.
MedLine Citation:
PMID:  10752763     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a 21-year-old male with childhood-onset familial nephrotic syndrome and frequent relapses who manifested toxicity or treatment resistance to corticosteroids, cyclophosphamide, cyclosporin-A, and tacrolimus. Monotherapy with mycophenolate mofetil (MMF) resulted in maintenance of clinical remission for 14 months without noticeable toxicity, while allowing resolution of steroid-induced side effects. Our observation suggests that MMF may be useful in maintaining remission in nephrotic patients who manifest toxicity to standard immunosuppressive agents.
Authors:
M Chandra; M Susin; C Abitbol
Related Documents :
9473823 - Congenital nephrotic syndrome of the finnish type: report of one case.
1130193 - Renal biopsy studies in 150 children with non-specific glomerulopathy.
17449523 - Severity of obstructive apnoea in children with down syndrome who snore.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric nephrology (Berlin, Germany)     Volume:  14     ISSN:  0931-041X     ISO Abbreviation:  Pediatr. Nephrol.     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-05-09     Completed Date:  2000-05-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8708728     Medline TA:  Pediatr Nephrol     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  224-6     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child, Preschool
Drug Resistance
Humans
Immunosuppressive Agents / adverse effects,  therapeutic use*
Male
Mycophenolic Acid / analogs & derivatives*,  therapeutic use
Nephrotic Syndrome / drug therapy*
Recurrence
Remission Induction
Retreatment
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 128794-94-5/mycophenolate mofetil; 24280-93-1/Mycophenolic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prognostic factors in Saudi children with posterior urethral valves.
Next Document:  The stressed neonatal kidney: from pathophysiology to clinical management of neonatal vasomotor neph...